Investor
TRV GP V, LLC
CIK 0001990717 · filed 2026-02-13 · SEC filing
13F book
$429.2M
Positions
3
Largest name
50.4%
Rapport Therapeutics, Inc. · RAPP
Est. mark
—
Need a prior quarter to estimate
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | RAPP | 7.14M | $216.5M | 50.4% | — | Held |
| Septerna, Inc. | SEPN | 6.22M | $173.3M | 40.4% | — | Held |
| Maze Therapeutics, Inc. | MAZE | 950.8K | $39.4M | 9.2% | — | Held |
Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.